Recombinant human R-spondin 1

N/A

Report date: 2022/10/21 11:22:16

Base Information

Drug NameRecombinant human R-spondin 1
Drug Alias NameRecombinant human futrin 3RSpo-1R-Spondin-1NU-206
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionDickkopf-related protein 1 inhibitorsWnt signalling pathway modulators
TargetsDickkopf-related protein 1
Therapy Area/IndicationsMucositisInflammatory Bowel DiseasesBone Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesArca Biopharma IncKyowa Hakko Kirin Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArca Biopharma IncKyowa Hakko Kirin Co Ltd
Active IndicationsN/A
Inactive IndicationsMucositisInflammatory Bowel DiseasesBone Diseases

Other Information

ATC CodeN/A
Related LinksN/A